← All medicines

Antiviral medicines

Ibalizumab-uiyk injection

Independent educational summary · Sources checked November 19, 2026

An HIV treatment used when other regimens have not adequately controlled infection.

Profile scope: Ibalizumab-uiyk injection. Confirm the exact product and route; formulations and combination products are not interchangeable.

Possible side effects

Loose stools, dizziness, stomach upset, or rash may occur.

Serious risks and warning signs

The NIH page describes observation during and after the infusion. It does not provide a separate serious-reaction list. Report unexpected symptoms during treatment and follow the infusion team's instructions; absence of a list does not establish absence of risk.

A question for your healthcare team

Which symptoms should I report during the infusion or after leaving the clinic?

What to do with this information

Discuss persistent or troubling symptoms with your prescriber or pharmacist. For severe breathing difficulty, collapse, a seizure, or inability to wake someone, seek emergency help. Read the linked medicine information for drug-specific instructions, including situations requiring immediate action. For routine treatment changes, consult your prescriber rather than changing your dose on your own. Follow the urgent action instructions above and in the linked medicine information.

Sources

Sources checked November 19, 2026. An original AI-assisted educational summary, not a complete adverse-effect or interaction list. This profile is part of the broader library expansion, not the original prescription-use ranking. Inclusion does not confirm current product availability or mean that risks outweigh benefits. This page has not been independently reviewed by a clinician.